UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000012522
Receipt number R000014557
Scientific Title Efficacy and Safety of Cytokines Versus Sunitinib as First-line Followed by Second-line Axitinib in the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Phase III Randomized Sequential Open-Label Study
Date of disclosure of the study information 2013/12/09
Last modified on 2023/01/16 13:12:45

No. Disposal Last modified on Item of update
1 Insert 2013/12/09 00:58:38
2 Update 2013/12/15 12:51:54 Key inclusion criteria
3 Update 2023/01/16 13:12:45 Recruitment status
Date of IRB
Last follow-up date